Ethiopia: Ethiopia to Immunize Over 1.8 Million Girls Against Human Papillomavirus
[WHO-AFRO] Addis Ababa -- A human papillomavirus (HPV) vaccination campaign that aims to immunize over 1.8 million 14-year-old girls in nine regions against HPV is underway. The campaign commenced on 10 January 2022 and will end on 22 January. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - January 23, 2022 Category: African Health Source Type: news

Covax, the Developing World ’ s Hope against COVID, Has Made It Only Halfway
Delivery of syringes for the vaccination campaign in El Salvador. Latin American countries have made steady progress in immunizing their populations, partly through direct negotiations between their governments and suppliers and partly through international cooperation. CREDIT: PAHO By Humberto MárquezCARACAS, Jan 20 2022 (IPS) The Covax initiative, the hope of the countries of the developing South to immunize their populations against COVID-19, only met half of its goals in 2021. And as 2022 begins, and the omicron variant of the virus is spreading fast, the scheme still depends on the decisions of pharmaceutical compani...
Source: IPS Inter Press Service - Health - January 20, 2022 Category: International Medicine & Public Health Authors: Humberto Marquez Tags: COVID-19 Development & Aid Editors' Choice Featured Global Global Governance Headlines Health Humanitarian Emergencies Regional Categories TerraViva United Nations COVAX COVID-19 vaccines Source Type: news

Tanzania: Health Teams Tasked in Hpv Awareness Creation
[Daily News] COMMUNITY Health Management Teams (CHMT) in district councils have been advised to step up efforts in raising awareness among members of the public on the benefits of Human Papillomavirus Vaccines (HPV1&HPV2) in protecting girls under 15 against cervical cancer. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - December 14, 2021 Category: African Health Source Type: news

Why More Kids Aren ’t Getting the HPV Vaccine
The human papillomavirus vaccine can prevent six potentially lethal malignancies, but inoculation is meeting with rising resistance from parents. (Source: NYT Health)
Source: NYT Health - December 13, 2021 Category: Consumer Health News Authors: Jane E. Brody Tags: Human Papillomavirus (HPV) Gardasil (Vaccine) Cervical Cancer Vaccination and Immunization Head and Neck Cancer Sexually Transmitted Diseases Parenting Teenagers and Adolescence Youth Cervarix (Vaccine) JAMA Pediatrics (Journal) Source Type: news

Tanzania: Send Your Daughters for Hpv Vaccination, Parents Urged
[Daily News] THE MINISTRY of Health, Community Development, Gender, Elderly and Children has urged parents to ensure that their daughters take the Human Papillomavirus Vaccine (HPV) to protect them from cervical cancer. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - December 1, 2021 Category: African Health Source Type: news

HPV Vaccine Has Protected Thousands Of People From Cervical Cancer, According To New Study
The HPV (human papillomavirus) vaccine pledged to help protect students between the ages of 12 and 13 from cervical cancer, among other cancers. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 1, 2021 Category: Pharmaceuticals Authors: Alice Broster, Contributor Tags: Healthcare /healthcare Innovation /innovation Source Type: news

Single-Dose HPV Vaccination Highly Effective Single-Dose HPV Vaccination Highly Effective
Only 15% of girls globally are vaccinated against human papillomavirus (HPV), but single-dose vaccination could pave the way for much better infection control, new research suggests.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 30, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

HPV Vaccination:'Dramatic' Reduction in Cervical Cancer HPV Vaccination:'Dramatic' Reduction in Cervical Cancer
New data from England show the success of the national human papillomavirus (HPV) vaccination program in preventing cervical cancer and noninvasive precursor lesions in young women.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 4, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Older HPV vaccine cuts cervical cancer rate up to 87%, study finds
Young women who were vaccinated against human papillomavirus in their teens with an older GlaxoSmithKline product called Cervarix had up to an 87% lower risk of developing cervical cancer linked... #glaxosmithkline #thelancet (Source: Reuters: Health)
Source: Reuters: Health - November 3, 2021 Category: Consumer Health News Source Type: news

HPV vaccination lowers cervical cancer risk up to 87%, British study finds
Becoming vaccinated against the human papillomavirus reduces a woman's risk for cervical cancer up to 87%, a study published Wednesday by the Lancet found. (Source: Health News - UPI.com)
Source: Health News - UPI.com - November 3, 2021 Category: Consumer Health News Source Type: news

Inovio, AstraZeneca terminate cancer vaccine partnership
MedImmune Ltd., the global biologics research and development arm of AstraZeneca (NYSE: AZN), is terminating a cancer therapy partnership it has with Inovio Pharmaceuticals. The partnership, formed in 2015, gave MedImmune of Gaithersburg, Maryland, exclusive rights to Inovio's experimental DNA-based cancer vaccine, known as INO-3112, for cancers caused by human papillomavirus (HPV) types 16 and 18. MedImmune renamed the new drug candidate as MED10457 after acquirin g its exclusive rights. The… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 2, 2021 Category: Pharmaceuticals Authors: John George Source Type: news

Schools Could Help More Kids Get the COVID-19 Vaccine. But History Has Some Warnings
Now that the U.S. Food and Drug Administration has authorized Pfizer-BioNTech’s vaccine for kids aged 5 to 11, the Biden Administration has signaled that it will rely on a “trusted messenger” to get information to parents and provide access to vaccines once they’re approved by the Centers for Disease Control and Prevention: schools. As part of the plan to deliver COVID-19 vaccines to the youngest population yet, schools will again take on a role they’ve assumed during health crises throughout American history: promoting vaccination to keep kids and communities safe from infectious disease. &ld...
Source: TIME: Health - November 1, 2021 Category: Consumer Health News Authors: Tara Law Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news

Schools Could Help More Kids Get the COVID-19 Vaccine. But History Has Some Warnings
Now that the U.S. Food and Drug Administration has authorized Pfizer-BioNTech’s vaccine for kids aged 5 to 11, the Biden Administration has signaled that it will rely on a “trusted messenger” to get information to parents and provide access to vaccines once they’re approved by the Centers for Disease Control and Prevention: schools. As part of the plan to deliver COVID-19 vaccines to the youngest population yet, schools will again take on a role they’ve assumed during health crises throughout American history: promoting vaccination to keep kids and communities safe from infectious disease. &ld...
Source: TIME: Science - November 1, 2021 Category: Science Authors: Tara Law Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news

Africa: UN Honours Henrietta Lacks, Whose Cells Transformed Medical Research Worldwide
[UN News] For the past seven decades, the cells of Henrietta Lacks, a Black American woman who died of cervical cancer, have saved countless lives, and made numerous scientific breakthroughs possible, such as the human papillomavirus and polio vaccines, drugs for HIV treatment, together with cancer and COVID-19 research. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - October 14, 2021 Category: African Health Source Type: news

MSD Pharmaceuticals launches gender-neutral HPV vaccine GARDASIL 9 in India
"Launching GARDASIL 9 is a crucial step towards advancing the mission of building a healthy young India by reducing the disease burden of HPV-related cancers and disease in the country," MSD India Region Managing Director Rehan A Khan said in a statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 29, 2021 Category: Pharmaceuticals Source Type: news